Opaleye Management as of Dec. 31, 2014
Portfolio Holdings for Opaleye Management
Opaleye Management holds 36 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Chimerix (CMRX) | 16.4 | $32M | 805k | 40.26 | |
| Agios Pharmaceuticals (AGIO) | 6.4 | $13M | 114k | 112.04 | |
| Cempra | 6.0 | $12M | 505k | 23.51 | |
| Retrophin | 5.7 | $11M | 920k | 12.24 | |
| Ariad Pharmaceuticals | 5.3 | $11M | 1.5M | 6.87 | |
| Pharmacyclics | 5.2 | $10M | 85k | 122.26 | |
| Clovis Oncology | 4.0 | $7.8M | 140k | 56.00 | |
| Tetraphase Pharmaceuticals | 3.8 | $7.5M | 190k | 39.71 | |
| Geron Corporation (GERN) | 3.0 | $5.9M | 1.8M | 3.25 | |
| Versartis | 2.7 | $5.3M | 235k | 22.45 | |
| Fibrogen (FGEN) | 2.6 | $5.2M | 191k | 27.34 | |
| Insys Therapeutics | 2.6 | $5.2M | 123k | 42.16 | |
| Ultragenyx Pharmaceutical (RARE) | 2.4 | $4.7M | 106k | 43.88 | |
| GenMark Diagnostics | 2.3 | $4.6M | 335k | 13.61 | |
| Ophthotech | 2.3 | $4.5M | 100k | 44.87 | |
| Kite Pharma | 2.2 | $4.4M | 76k | 57.67 | |
| Codexis (CDXS) | 2.2 | $4.3M | 1.7M | 2.52 | |
| Medgenics | 2.2 | $4.3M | 850k | 5.06 | |
| Imprimis Pharmaceuticals | 2.1 | $4.2M | 560k | 7.50 | |
| Oncothyreon | 1.9 | $3.8M | 2.0M | 1.90 | |
| Cardiovascular Systems | 1.9 | $3.8M | 125k | 30.08 | |
| Flamel Technologies | 1.8 | $3.5M | 205k | 17.13 | |
| D Fluidigm Corp Del (LAB) | 1.6 | $3.2M | 95k | 33.73 | |
| Paratek Pharmaceuticals | 1.6 | $3.1M | 80k | 38.55 | |
| Trillium Therapeutics, Inc. Cmn | 1.5 | $3.0M | 333k | 9.00 | |
| Supernus Pharmaceuticals (SUPN) | 1.5 | $2.9M | 350k | 8.30 | |
| Catalyst Pharmaceutical Partners (CPRX) | 1.5 | $2.9M | 975k | 2.97 | |
| Alnylam Pharmaceuticals (ALNY) | 1.4 | $2.8M | 29k | 97.01 | |
| Horizon Pharma | 1.4 | $2.8M | 220k | 12.89 | |
| Accelr8 Technology | 1.0 | $1.9M | 100k | 19.19 | |
| Celgene Corp right 12/31/2011 | 0.9 | $1.8M | 575k | 3.15 | |
| Tenax Therapeutics | 0.8 | $1.7M | 440k | 3.84 | |
| Evoke Pharma | 0.7 | $1.4M | 240k | 5.90 | |
| Neurocrine Biosciences (NBIX) | 0.5 | $1.0M | 45k | 22.33 | |
| Cara Therapeutics (CARA) | 0.4 | $798k | 80k | 9.98 | |
| Biolinerx Ltd-spons | 0.2 | $405k | 250k | 1.62 |
